PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Stu ...
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.095
https://www.valueinhealthjournal.com/article/S1098-3015(21)00312-0/fulltext
Title :
PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Stu ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00312-0&doi=10.1016/j.jval.2021.04.095
First page :
Section Title :
Open access? :
No
Section Order :
10444